St Jude CE marks Accent, becoming second MRI-safe pacemaker player in Europe
This article was originally published in Clinica
Executive Summary
St Jude Medical has CE marked its Accent MRI pacemaker, making it the second company to launch an MRI-compatible pacemaker on the European market. The firm has also CE marked the Tendril MRI lead, which connects the pacemaker to the patient's heart.
You may also be interested in...
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.